glp-1 inhibitor Complementary Yet Distinct Roles of Receptor Agonists and SGLT2 Inhibitors in Cardiovascular Risk Reduction GLP-1 receptor agonists | How
Description
The rationale for combining it with retatrutide centers on complementary mechanisms for body composition optimization
[DOI] [PMC free article] [PubMed] [Google Scholar] 87.Colhoun H.M., Hasenour C., Riddle M.C., Branch K., Konig M., Atisso C., Lakshmanan M., Mody R., Gerstein H.C
This may increase the risk of low blood sugar or other related complications
Cardiovascular and renal effectiveness of GLP-1 receptor agonists vs
doi: 10.3390/ijms25158214
Lancet Neurol (2015) 14(9):94555
